The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease

Table 3 Clinical data in DCMR-neg patients

	DCMR-neg patients			Patients without invasive angiography
	no invasive angio	invasive angio		no event	event
	n = 833	n = 90	p^†	n = 825	n = 8	p^‡
Clinical characteristics
Age [years]	62 ± 11	64 ± 11	0.27	62 ± 11	59 ± 10	0.28
Male, %	62	72	0.06	62	71	0.61
Body mass index [kg/m2]	27 ± 4	27 ± 4	0.77	27 ± 4	28 ± 6	0.29
LVEF	58 ± 6	58 ± 8	0.31	58 ± 6	53 ± 14	0.76
Hypertension, %	70	76	0.26	70	86	0.36
Hyperlipidemia, %	57	71	0.01	57	86	0.13
Diabetes mellitus, %	19	22	0.39	18	29	0.49
Smoking, %	30	41	0.03	30	29	0.93
Family history, %	34	30	0.49	34	14	0.28
Framingham risk score	15 ± 11	16 ± 11	0.56	15 ± 11	18 ± 9	0.7
Known CAD, %	32	58	<0.001	32	57	0.15
Prior myocardial infarction, %	22	30	0.11	30	71	0.03
Prior PCI, %	25	52	<0.001	25	43	0.38
Prior CABG, %	10	22	0.001	10	29	0.16
Medication, %
Aspirin	60	87	<0.001	60	86	0.25
Betablocker	62	76	0.01	61	100	0.04
ACE inhibitor	48	67	0.001	48	57	0.71
Angiotensin receptor blocker	25	20	0.4	25	14	0.53
Calcium channel blocker	21	27	0.28	21	14	0.65
Statin	57	87	<0.001	56	71	0.43
Diuretic	32	46	0.02	32	29	0.83

Values are expressed as mean ± SD or %, ^†DCMR-pos patients with vs. without invasive coronary angiography, ^‡DCMR-pos patients with vs. without coronary stenosis

ISSN: 1532-429X